Ocular Systems, Inc. has received FDA clearance to market EndoSerter, a device for inserting replacement cells into the eye during a corneal transplant. The device, invented in Winston-Salem and manufactured in the Piedmont Triad Research Park, is used for a type of corneal transplant known as endothelial keratoplasty. The device inserts cells into the eye, protecting corneal tissue from damage. It is among other developments that will help OSI move closer to commercializing an endothelial cell product for cornea transplantation using technology developed by the Wake Forest University Institute for Regenerative Medicine. Read more.
